➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
McKesson
Harvard Business School
Baxter

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for BTA798

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug BTA798?

BTA798 is an investigational drug.

There have been 5 clinical trials for BTA798. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Infection, Respiratory Tract Infections, and Communicable Diseases. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Vaxart, and Aviragen Therapeutics.

Recent Clinical Trials for BTA798
TitleSponsorPhase
A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy VolunteersAviragen TherapeuticsPhase 1
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionBiota Pharmaceuticals, Inc.Phase 2
A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female VolunteersBiota Scientific Management Pty LtdPhase 1

See all BTA798 clinical trials

Clinical Trial Summary for BTA798

Top disease conditions for BTA798
Top clinical trial sponsors for BTA798

See all BTA798 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
McKesson
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.